Chemoinformaics analysis of 3alpha-(3,4,5-Trimethoxybenzoyloxy)tropane
| Molecular Weight | 335.4 | nRot | 5 |
| Heavy Atom Molecular Weight | 310.2 | nRig | 1 |
| Exact Molecular Weight | 335.173 | nRing | 3 |
| Solubility: LogS | -3.271 | nHRing | 2 |
| Solubility: LogP | 3.578 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 25 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 51.8398 |
| nHD | 0 | BPOL | 34.6022 |
| QED | 0.455 |
| Synth | 2.283 |
| Natural Product Likeliness | 0.785 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.017 |
| Pgp-sub | 0.002 |
| HIA | 0.003 |
| CACO-2 | -4.354 |
| MDCK | 0.0000232 |
| BBB | 0.993 |
| PPB | 0.569803 |
| VDSS | 1.189 |
| FU | 0.427509 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.868 |
| CYP2c19-inh | 0.685 |
| CYP2c19-sub | 0.86 |
| CYP2c9-inh | 0.361 |
| CYP2c9-sub | 0.721 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.248 |
| CYP3a4-inh | 0.162 |
| CYP3a4-sub | 0.215 |
| CL | 8.252 |
| T12 | 0.497 |
| hERG | 0.04 |
| Ames | 0.008 |
| ROA | 0.036 |
| SkinSen | 0.822 |
| Carcinogencity | 0.079 |
| EI | 0.978 |
| Respiratory | 0.553 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.610947 |